advanced search
PROFITABLE ASSEMBLY AUTOMATION THROUGH USE OF STANDARDISED MACHINE PLATFORMS
RESPIRATORY
Reiner Zeidler
teamtechnik
PROFITABLE ASSEMBLY AUTOMATION THROUGH USE OF STANDARDISED MACHINE PLATFORMS
Reiner Zeidler describes the company’s modular TEAMED production system, and how it meets the inhaler device industry’s needs – from early development applications right through to commercial-scale manufacture.
MEETING EVOLVING BIOLOGICS & SMALL MOLECULES NEEDS
MICRONEEDLES
Dr Lisa A Dick
MEETING EVOLVING BIOLOGICS & SMALL MOLECULES NEEDS
Lisa A Dick provides a run-down of the concept, design and development of the company’s microneedle drug delivery platform, both hollow and solid needle arrays, including recent clinical trials of the hollow-needle device.
AQUARMED™: TRANSDERMAL DELIVERY USING NOVEL COMPONENTS
TRANSDERMAL
Prof Marc Brown
MedPharm
AQUARMED™: TRANSDERMAL DELIVERY USING NOVEL COMPONENTS
Marc Brown, Adrian Williams and James Gibbons explain how the company has developed AquaRMed and describe the potential benefits it could offer patients and companies alike.
Q&A: SUCCESSFUL MASS PRODUCTION OF AN INNOVATIVE DRUG DELIVERY TECHNOLOGY
MICRONEEDLES
Dr Jung Dong Kim
Q&A: SUCCESSFUL MASS PRODUCTION OF AN INNOVATIVE DRUG DELIVERY TECHNOLOGY
Jung Dong Kim answers questions about the company, its capabilities, and the mass production of an innovative dissolving microstructure drug delivery technology.
HIGHLY CUSTOMISABLE HOLLOW POLYMER MICRONEEDLE SOLUTIONS
MICRONEEDLES
Dr Marion Sausse Lhernould
HIGHLY CUSTOMISABLE HOLLOW POLYMER MICRONEEDLE SOLUTIONS
Marion Sausse Lhernould, Serge Tailler, Michel Deleers and Alain Delchambre present a hollow microneedle delivery device manufactured using a novel proprietary process.
LEVERAGING NEEDS-CHARACTERISATION TO FUEL SMARTER DESIGN
EXPERT VIEW
Mark Tunkel
LEVERAGING NEEDS-CHARACTERISATION TO FUEL SMARTER DESIGN
Mark Tunkel and Craig Scherer discuss how needs-characterisation is becoming an essential part of combination product strategy in an increasingly competitive market.
INTERVIEW: JEANNIE JOUGHIN, CSL BEHRING
INTERVIEW
Dr Jeannie Joughin
INTERVIEW: JEANNIE JOUGHIN, CSL BEHRING
Jeannie Joughin speaks exclusively with ONdrugDelivery Magazine about CSL Behring’s agreement with Enable, how it came about, what it means to the two companies, and how it’s going so far.
RECONSTYRINGE<sup>®</sup>: FULL INTEGRATION OF ALL FUNCTIONS & PARTS, FULLY AUTOMATED RECONSTITUTION
INJECTION
Ludwig D Weibel
RECONSTYRINGE®: FULL INTEGRATION OF ALL FUNCTIONS & PARTS, FULLY AUTOMATED RECONSTITUTION
Ludwig Weibel and Hans Peter Manser introduce the Reconstyringe® system, which offers a fully automated reconstitution of lyophilised drugs.
A STATE-OF-THE-ART HIGH-VOLUME MANUFACTURING LINE FOR A DISPOSABLE PEN PLATFORM PRODUCT
PREFILLED SYRINGES
Tobias Nemeth
Ypsomed
A STATE-OF-THE-ART HIGH-VOLUME MANUFACTURING LINE FOR A DISPOSABLE PEN PLATFORM PRODUCT
Tobias Nemeth outlines the advantages of platform product development and manufacture and goes on to describe the implementation of the UnoPen™ high-volume manufacturing line.
THE EVOLUTION OF FLUOROPOLYMER COATINGS FOR PARENTERAL PACKAGING
PREFILLED SYRINGES
Dr Susan Dounce
Datwlyer
THE EVOLUTION OF FLUOROPOLYMER COATINGS FOR PARENTERAL PACKAGING
Susan M. Dounce describes how plunger coating has become about more than barrier properties.
CRACK PREVENTION & PROCESS CONTROLS IN PREFILLABLE SYRINGE MANUFACTURING
PREFILLED SYRINGES
Dr Andrea Behrenswerth
Gerresheimer
CRACK PREVENTION & PROCESS CONTROLS IN PREFILLABLE SYRINGE MANUFACTURING
Andrea Behrenswerth and Marc-Oliver Luther both of Gerresheimer Bünde, and Bernhard Hinsch of Hinsch Consulting (Hamburg, Germany), explain the most frequently encountered types of defects, their causes and specific approaches to process optimisation.
HUMAN FACTORS ENGINEERING, COMBINATION PRODUCT REGULATION AND INNOVATIVE SAFETY SYSTEMS
PREFILLED SYRINGES
Anastasie Formey de Saint Louvent
BD (Becton Dickinson & Company)
HUMAN FACTORS ENGINEERING, COMBINATION PRODUCT REGULATION AND INNOVATIVE SAFETY SYSTEMS
Sarah Malka and Anastasie Formey de Saint Louvent describe how BD integrates human factors engineering and patient-centric design into an innovative partnering model for the development of new products.
OMPI NEXA SYRINGES: THE IDEAL SOLUTION FOR THE MOST DEMANDING DRUGS
PREFILLED SYRINGES
Alessandro Morandotti
Stevanato Group
OMPI NEXA SYRINGES: THE IDEAL SOLUTION FOR THE MOST DEMANDING DRUGS
Alessandro Morandotti introduce the Ompi Nexa Syringe, and describe in detail how its design fulfills the challenging quality requirements for prefilled syringes used for the storage and delivery of biological molecules.
CREDENCE MEDSYSTEMS & THE CREDENCE COMPANION SAFETY SYRINGE SYSTEM
PREFILLED SYRINGES
John Merhige
Credence MedSystems
CREDENCE MEDSYSTEMS & THE CREDENCE COMPANION SAFETY SYRINGE SYSTEM
John A Merhige summarises the Credence Companion Safety Syringe System, and how it fits with the company’s core philosophy of Innovation Without Change for the benefit of biopharmaceutical partners.
USING PREFILLABLE SYRINGES FOR BIOPHARMACEUTICALS – DEVELOPMENT & CHALLENGES
PREFILLED SYRINGES
William Dierick
Terumo Medical Care Solutions
USING PREFILLABLE SYRINGES FOR BIOPHARMACEUTICALS – DEVELOPMENT & CHALLENGES
William Dierick and Keisuke Yoshino describe the development of Terumo’s PLAJEXTM prefillable syringe system, which combines specific features of a COP syringe with the proprietary i-coatingTM technology to create a silicone oil-free system.
FOUR WAYS POLYMERS TRUMP GLASS FOR CONTAINING CUTTING-EDGE INJECTABLE BIOLOGICS
PREFILLED SYRINGES
Dr Nicolas Brandes
West Pharmaceutical Services
FOUR WAYS POLYMERS TRUMP GLASS FOR CONTAINING CUTTING-EDGE INJECTABLE BIOLOGICS
Nicolas Brandes makes the case that polymers offer superior benefits compared with glass as a material for primary containers and delivery systems for parenteral drugs, including in particular biologics.
COMPANY SHOWCASE: PHILLIPS-MEDISIZE
PREFILLED SYRINGES
Phillips-Medisize
COMPANY SHOWCASE: PHILLIPS-MEDISIZE
Phillips-Medisize is a global-leader in outsource design, development and technology-driven manufacturing.
PSIVIDA AND OPHTHALMIC DRUG DELIVERY
OCULAR
Dr Paul Ashton
EyePoint Pharmaceuticals
PSIVIDA AND OPHTHALMIC DRUG DELIVERY
Paul Ashton describes how much of the progress that has been made recently in the treatment of ophthalmic diseases can be ascribed to effective drug delivery systems, and outlines some of the delivery technologies and resulting products for which pSivida has been responsible.
MODELLING OCULAR DELIVERY USING COMPUTATIONAL FLUID DYNAMICS
OCULAR
Dr Marc Horner
ANSYS, Inc
MODELLING OCULAR DELIVERY USING COMPUTATIONAL FLUID DYNAMICS
Paul Missel and Marc Horner describe the use of computational fluid dynamics simulations to predict drug flow and temperature inside the eye, and provide examples of applications modelling.
HUGE THERAPEUTIC ADVANCES: BIGGER DRUG DELIVERY OPPORTUNITIES
EXPERT VIEW
Dr Paul Ashton
HUGE THERAPEUTIC ADVANCES: BIGGER DRUG DELIVERY OPPORTUNITIES
Paul Ashton gives an introduction into the current state of the ophthalmics market.
AN INTEGRATED PIPELINE OF OPHTHALMIC PRODUCTS BASED ON EYESOL™ DELIVERY TECHNOLOGY
OCULAR
Dr Dieter Scherer
AN INTEGRATED PIPELINE OF OPHTHALMIC PRODUCTS BASED ON EYESOL™ DELIVERY TECHNOLOGY
Dieter Scherer describes two of Novaliq’s most advanced products: NovaTears®, a wetting agent for the ocular surface, and CyclASol®, a clear formulation of Cyclosporin A. Both products use Novaliq’s semifluorinated alkane technology, EyeSol®.
OCULAR DRUG DELIVERY TECHNOLOGIES: EXCITING TIMES AHEAD
EXPERT VIEW
Dr Ilva D Rupenthal
OCULAR DRUG DELIVERY TECHNOLOGIES: EXCITING TIMES AHEAD
Ilva Rupenthal gives a sector overview of the occular drug delivery space.
EXCIPIENT SELECTION FOR OPHTHALMIC OINTMENTS
OCULAR
Dr Janice Cacace
EXCIPIENT SELECTION FOR OPHTHALMIC OINTMENTS
Janice Cacace and Travis Webb describe the physical properties of petrolatums as they relate to the comfort and efficacy of formulations of ophthalmic ointments.
COMPANY SHOWCASE: GRAYBUG
Michael O'Rourke
COMPANY SHOWCASE: GRAYBUG
GrayBug is advancing ophthalmic therapeutics through a continuum of polymerbased drug delivery platforms and innovative products offering sustained competitive advantage.

See what ondrugdelivery's readers and contributors think


Abby Lockwood Opus Strategy photo
Abby Lockwood
Consultant
Plan Strategic

ONdrugDelivery Magazine is a great resource that brings a lot of value to the work my team and I are doing in the area of drug delivery. The device-specific content as well as the broader discussions surrounding industry trends and issues are extremely informative and very well written.


Li-Chun Tsou, PhD, MBA
Principal Engineer
Merck & Co

Your website and publication is a great asset for me. I’d recommend your publication to my colleagues. I am sure that we will gain knowledge and update information through your timely report. Thanks for making it available.


Matt Kempton user photo
Matt Kempton
Snr Project Engineer
Corning Incorporated

I am extremely impressed with the comprehensive presentation of information and problem/solution points detailed ... Kudos to you for an extremely well written article with succinct and robust scientific body of knowledge.


Dr Cristian Vilos

I‘m working on the development of microparticles for the release of veterinary antibiotics, and polymeric nanoparticles for siRNA and chemotherapeutic delivery. ONdrugDelivery has been a very usefull platform to connect the scientific research, and marketed drug development.


Top